Somatotype, the risk of hydroxychloroquine retinopathy, and safe daily dosing guidelines
David J Browning, Chong Lee Department of Ophthalmology, Charlotte Eye, Ear, Nose and Throat Associates, PA, Charlotte, NC, USA Purpose: The aim of this study was to determine whether somatotype influences the risk of hydroxychloroquine (HC) retinopathy (HCR) and whether dosing by real body weight...
Guardado en:
Autores principales: | Browning DJ, Lee C |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7e59e3dbe6874e65916c113603bc824a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Incidence of and risk factors for chloroquine and hydroxychloroquine retinopathy in Thai rheumatologic patients
por: Tangtavorn N, et al.
Publicado: (2016) -
Coding patterns used by ophthalmologists for hydroxychloroquine retinal toxicity
por: Chiu SY, et al.
Publicado: (2018) -
Hydroxychloroquine for treatment of rheumatoid arthritis: multifocal electroretinogram and laser flare-cell photometry study
por: Sebastiani S, et al.
Publicado: (2017) -
Audiologic evaluation in systemic lupus erythematosus patients and impact of hydroxychloroquine therapy
por: Samar Tharwat, et al.
Publicado: (2022) -
Clinical Efficacy of Hydroxychloroquine or Chloroquine in Patients with COVID-19: An Umbrella Review
por: Kavous Shahsavarinia, et al.
Publicado: (2021)